23:58:53 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Prenumeration

Kalender

2025-02-20 Bokslutskommuniké 2024
2024-10-31 Kvartalsrapport 2024-Q3
2024-08-23 Kvartalsrapport 2024-Q2
2024-05-08 X-dag ordinarie utdelning LUMITO 0.00 SEK
2024-05-07 Kvartalsrapport 2024-Q1
2024-05-07 Årsstämma 2024
2024-02-22 Bokslutskommuniké 2023
2023-10-31 Kvartalsrapport 2023-Q3
2023-08-17 Kvartalsrapport 2023-Q2
2023-05-26 X-dag ordinarie utdelning LUMITO 0.00 SEK
2023-05-25 Årsstämma 2023
2023-05-03 Kvartalsrapport 2023-Q1
2023-02-23 Bokslutskommuniké 2022
2022-11-02 Kvartalsrapport 2022-Q3
2022-08-18 Kvartalsrapport 2022-Q2
2022-05-30 X-dag ordinarie utdelning LUMITO 0.00 SEK
2022-05-27 Årsstämma 2022
2022-05-06 Kvartalsrapport 2022-Q1
2022-02-17 Bokslutskommuniké 2021
2021-11-24 Extra Bolagsstämma 2021
2021-10-20 Kvartalsrapport 2021-Q3
2021-08-18 Kvartalsrapport 2021-Q2
2021-05-28 X-dag ordinarie utdelning LUMITO 0.00 SEK
2021-05-27 Årsstämma 2021
2021-04-28 Kvartalsrapport 2021-Q1
2021-02-17 Bokslutskommuniké 2020
2020-11-03 Kvartalsrapport 2020-Q3
2020-08-20 Kvartalsrapport 2020-Q2
2020-05-28 X-dag ordinarie utdelning LUMITO 0.00 SEK
2020-05-27 Årsstämma 2020
2020-04-28 Kvartalsrapport 2020-Q1
2020-02-17 Bokslutskommuniké 2019
2019-10-31 Kvartalsrapport 2019-Q3
2019-08-21 Kvartalsrapport 2019-Q2
2019-06-04 Årsstämma 2019
2019-05-23 X-dag ordinarie utdelning LUMITO 0.00 SEK
2019-04-30 Kvartalsrapport 2019-Q1
2019-02-15 Bokslutskommuniké 2018

Beskrivning

LandSverige
ListaNordic SME Sweden
SektorHälsovård
IndustriMedicinteknik
Lumito specialiserar sig på medicinsk teknik för digital patologi. Bolaget strävar efter att förbättra vävnadsdiagnostiken med sin patenterade teknologi baserad på uppkonverterade nanopartiklar. Bolaget planerar att initialt lansera sin första produkt för forskningslaboratorier. Bolaget bildades under 2010 som en spinoff från en forskargrupp vid Lunds universitets avdelning för atomfysik och lasercentrum. Lumito har sitt huvudkontor i Lund.
2023-12-15 08:30:00

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, CANADA, NEW ZEALAND, HONG KONG, JAPAN, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, BELARUS, RUSSIA OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES. PLEASE REFER TO IMPORTANT INFORMATION AT THE END OF THE PRESS RELEASE.

Lumito AB (publ) (”Lumito” or the ”Company”) has completed the issue of units, consisting of warrants of series TO5 and TO6 with preferential rights for existing shareholders (the "Issue"), which the board of directors resolved on November 10, 2023 (changes to the terms and conditions for the Issue were resolved and announced on November 17, 2023). The outcome concludes that 3,810,412 units have been subscribed through the use of unit rights, corresponding to approximately 88.6 percent of the Issue. Additionally, the Issue has been fully subscribed multiple times without the support of unit rights. Thus, the Issue has been fully subscribed. The Issue will provide the Company with approximately SEK 43 thousand before issue costs.

Comment from Mattias Lundin, CEO
I am very pleased and grateful for the interest our shareholders have shown in this issue of warrants, and the fact that there has also been a great interest in participating even without priority is of course very encouraging. We look forward to next year and our plans for the launch of SCIZYS where the capital will be of great use.

Final outcome
The subscription period in the Issue ended December 13, 2023. The final outcome shows that a total of 3,810,412 units have been subscribed for using unit rights, corresponding to 88.6 percent of the Issue. Additionally, the Issue has been fully subscribed multiple times without the support of unit rights. Thus, the Issue has been fully subscribed. Consequently, 4,300,781 units have been allotted to subscribers, corresponding to 100 percent of the Issue. Each unit consists of four (4) warrants of series TO5 and four (4) warrants of series TO6. In total, 4,300,781 units were subscribed, corresponding to 17,203,124 warrants of series TO5 and 17,203,124 warrants of series TO6.

Upon full exercise of all warrants of series TO5 issued in the Issue, the Company may be provided with an additional capital injection of up to approximately SEK 20.6 million. Upon full exercise of all warrants of series TO6 issued in the Issue, the Company may be provided with an additional capital injection of up to approximately SEK 24.1 million.

Allotment of units subscribed without the support of unit rights
Allotment of units subscribed for without the support of unit rights has taken place in accordance with what is stated in the prospectus that the Company published on November 27, 2023, due to the Issue (the "Prospectus"). Notification of such allocation is announced separately through settlement notes. Nominee-registered shareholders receive notification of allotment in accordance with instructions from the respective nominee.

Trading with paid subscribed units (”BTU”)
Trading with BTU takes place until BTU is converted to warrants of series TO5 and warrants of series TO6, which will be converted upon registration of the Issue at the Swedish Companies Registration Office, expected to take place during week 52, 2023.

Shares, share capital and dilution
If all warrants of series TO5 (comprising warrants of series TO5 issued within the scope of the Issue as well as warrants of series TO5 previously issued according to public announcements from the Company) are fully exercised for subscription of new shares in the Company, the number of shares in the Company will increase with an additional 34,406,248 shares, from 206,437,488 shares to 240,843,736 shares, and the share capital will increase with an additional SEK 860,156.20, from SEK 5,160,937.20 to SEK 6,021,093.40, corresponding to a dilution of 14.3 percent in the number of shares.

If all warrants of series TO6 (comprising warrants of series TO6 issued within the scope of the Issue as well as warrants of series TO6 previously issued according to public announcements from the Company) are fully exercised for subscription of new shares in the Company, the number of shares in the Company will increase with an additional 34,406,248 shares, from 240,843,736 shares to 275,249,984 shares, and the share capital will increase with an additional SEK 860,156.20, from SEK 6,021,093.40 to SEK 6,881,249.60, corresponding to a dilution of 12.5 percent in the number of shares.

Warrants of series TO5

  • Each warrant of series TO5 entitles the holder to subscribe for one (1) new share in the Company. The subscription price for shares subscribed for using the warrants of series TO5 is 70 percent of the volume-weighted average price of the Company's share during the period from May 13, 2024 to May 24, 2024, however, not less than the share's quotient value (currently SEK 0.025) and not more than SEK 1.20.
  • The warrants of series TO5 can be exercised for the subscription of new shares during the period from May 27, 2024 to June 10, 2024.
  • Upon full subscription in the Issue and full exercise of all warrants of series TO5 within the scope of the offered units, the Company may receive a maximum of approximately SEK 41.3 million before transaction costs.
  • The warrants of series TO5 are intended to be admitted to trading on NGM Nordic SME after final registration with the Swedish Companies Registration Office.
  • Full terms and conditions for the warrants of series TO5 are available on the Company's website, www.lumito.se.

Warrants of series TO6

  • Each warrant of series TO6 entitles the holder to subscribe for one (1) new share in the Company. The subscription price for shares subscribed for using the series TO6 warrants is 70 percent of the volume-weighted average price of the Company's share during the period from October 21, 2024 to November 1, 2024, however, not less than the share's quotient value (currently SEK 0.025) and not more than SEK 1.40.
  • The warrants of series TO6 can be exercised for the subscription of new shares during the period from November 4, 2024 to November 15, 2024.
  • Upon full subscription in the Issue and full exercise of all warrants of series TO6 within the scope of the offered units, the Company may receive a maximum of approximately SEK 48.2 million before transaction costs.
  • The warrants of series TO6 are intended to be admitted to trading on NGM Nordic SME after final registration with the Swedish Companies Registration Office.
  • Full terms and conditions for the warrants of series TO6 are available on the Company's website, www.lumito.se.

Advisers
Mangold Fondkommission AB is financial adviser and Advokatfirman Lindahl KB is legal advisor Lumito in connection with the Issue.